Since the majority of PTC are driven by oncoproteins that activate the MAPK signalling pathway, we hypothesized that miR-204-5p could inhibit invasion of thyroid cancer cells by targeting effectors of this pathway and, more specifically, by targeting directly HMGA2, a critical regulator in cancer development that plays a pivotal role in EMT. This evidence concerns the gene HMGA2 and thyroid cancer.